Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by JenaValve Technology, Inc.

JenaValve‘s Trilogy™ System Featured in Live Procedure at TCT 2025
From JenaValve Technology, Inc.
Via GlobeNewswire
JenaValve Announced ESC Guidelines Recognize TAVI as Class IIb Recommendation for Aortic Regurgitation
From JenaValve Technology, Inc.
Via GlobeNewswire
JenaValve Responds to FTC’s Action Against Proposed Edwards Lifesciences Acquisition
From JenaValve Technology, Inc.
Via GlobeNewswire
JenaValve Announces First Patient Enrolled in ARTIST Randomized Controlled Trial (RCT) Evaluating the Trilogy™ System in Aortic Regurgitation (AR)
From JenaValve Technology, Inc.
Via GlobeNewswire
JenaValve's Trilogy™ THV System Procedures Live Broadcast at New York Valves 2025
From JenaValve Technology, Inc.
Via GlobeNewswire
JenaValve Announces Late-Breaking Data from the ALIGN-AR Pivotal Trial
From JenaValve Technology, Inc.
Via GlobeNewswire
JenaValve Announces First Case for Inclusion in JENA-VAD Registry
From JenaValve Technology, Inc.
Via GlobeNewswire
JenaValve Presents ALIGN-AR 2-Year Follow-Up Data at TCT 2024 and Announces Commencement of ARTIST Randomized Controlled Trial (RCT)
From JenaValve Technology, Inc.
Via GlobeNewswire
JenaValve Announces Publication of ALIGN-AR Pivotal Trial Results in The Lancet
From JenaValve Technology, Inc.
Via GlobeNewswire
JenaValve’s Trilogy THV System Highlighted at CRT 2024
From JenaValve Technology, Inc.
Via GlobeNewswire
JenaValve Featured at the PCR London Valves 2023
From JenaValve Technology, Inc.
Via GlobeNewswire
JenaValve Announces Partnership with the American Society of Echocardiography (ASE) to Advance Detection and Diagnosis of Aortic Regurgitation
From JenaValve Technology, Inc.
Via GlobeNewswire
JenaValve Announces Late-Breaking Data from the ALIGN-AR Pivotal Trial Meeting Safety and Efficacy Endpoints
From JenaValve Technology, Inc.
Via GlobeNewswire
JenaValve Announces ALIGN-AR Pivotal Data to be Presented During the Late-Breaking Clinical Trial Sessions at TCT 2023
From JenaValve Technology, Inc.
Via GlobeNewswire
JenaValve Appoints Shlomi Nachman to Board of Directors
From JenaValve Technology, Inc.
Via GlobeNewswire
JenaValve Announces First Trilogy Heart Valve Systems Implanted in Asia
From JenaValve Technology, Inc.
Via GlobeNewswire
JenaValve Appoints Ken MacLeod, Ph.D. to Board of Directors
From JenaValve Technology, Inc.
Via GlobeNewswire
JenaValve Appoints Dan Dearen to Board of Directors
From JenaValve Technology, Inc.
Via GlobeNewswire
JenaValve Appoints Duane Pinto, MD, MPH, as Chief Medical Officer
From JenaValve Technology, Inc.
Via GlobeNewswire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.